Cargando…
Acidic Fibroblast Growth Factor in Spinal Cord Injury
Spinal cord injury (SCI), with an incidence rate of 246 per million person-years among adults in Taiwan, remains a devastating disease in the modern day. Elderly men with lower socioeconomic status have an even higher risk for SCI. Despite advances made in medicine and technology to date, there are...
Autores principales: | Ko, Chin-Chu, Tu, Tsung-Hsi, Wu, Jau-Ching, Huang, Wen-Cheng, Cheng, Henrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Spinal Neurosurgery Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944993/ https://www.ncbi.nlm.nih.gov/pubmed/30653905 http://dx.doi.org/10.14245/ns.1836216.108 |
Ejemplares similares
-
Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor
por: Ko, Chin-Chu, et al.
Publicado: (2018) -
The Application of an Omentum Graft or Flap in Spinal Cord Injury
por: Fay, Li-Yu, et al.
Publicado: (2021) -
Characterizing the Neuroprotective Effects of S/B Remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) in Spinal Cord Injury
por: Tu, Tsung-Hsi, et al.
Publicado: (2019) -
Multifaceted Benefits of GDF11 Treatment in Spinal Cord Injury: In Vitro and In Vivo Studies
por: Tsai, May-Jywan, et al.
Publicado: (2022) -
Fibroblast growth factors in the management of spinal cord injury
por: Zhou, Yulong, et al.
Publicado: (2017)